Bajaj Healthcare Limited (BAJAJHCARE) - Total Liabilities
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has total liabilities worth Rs3.52 Billion INR (≈ $38.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Bajaj Healthcare Limited to assess how effectively this company generates cash.
Bajaj Healthcare Limited - Total Liabilities Trend (2011–2025)
This chart illustrates how Bajaj Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Check Bajaj Healthcare Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Bajaj Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Bajaj Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Siam Pan Group PCL
BK:SPG
|
Thailand | ฿457.05 Million |
|
Bcl Industries Limited
NSE:BCLIND
|
India | Rs7.94 Billion |
|
Gandhi Special Tubes Limited
NSE:GANDHITUBE
|
India | Rs248.47 Million |
|
Action SA
WAR:ACT
|
Poland | zł314.76 Million |
|
Axcen Photonics
TWO:6530
|
Taiwan | NT$64.67 Million |
|
DreamCIS Inc
KQ:223250
|
Korea | ₩60.03 Billion |
|
Cti Logistics Ltd
AU:CLX
|
Australia | AU$184.48 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Bajaj Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BAJAJHCARE stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bajaj Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bajaj Healthcare Limited (2011–2025)
The table below shows the annual total liabilities of Bajaj Healthcare Limited from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs3.67 Billion ≈ $39.68 Million |
-24.63% |
| 2024-03-31 | Rs4.87 Billion ≈ $52.64 Million |
-8.81% |
| 2023-03-31 | Rs5.34 Billion ≈ $57.73 Million |
+35.95% |
| 2022-03-31 | Rs3.93 Billion ≈ $42.46 Million |
+46.93% |
| 2021-03-31 | Rs2.67 Billion ≈ $28.90 Million |
+53.45% |
| 2020-03-31 | Rs1.74 Billion ≈ $18.83 Million |
+26.42% |
| 2019-03-31 | Rs1.38 Billion ≈ $14.90 Million |
-10.86% |
| 2018-03-31 | Rs1.55 Billion ≈ $16.71 Million |
+28.51% |
| 2017-03-31 | Rs1.20 Billion ≈ $13.00 Million |
-0.12% |
| 2016-03-31 | Rs1.20 Billion ≈ $13.02 Million |
+12.75% |
| 2015-03-31 | Rs1.07 Billion ≈ $11.55 Million |
-6.22% |
| 2014-03-31 | Rs1.14 Billion ≈ $12.31 Million |
+12.27% |
| 2013-03-31 | Rs1.01 Billion ≈ $10.97 Million |
+11.64% |
| 2012-03-31 | Rs908.41 Million ≈ $9.82 Million |
+23.55% |
| 2011-03-31 | Rs735.24 Million ≈ $7.95 Million |
-- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more